Literature DB >> 6419907

Staphylococcus aureus bacteraemia: 400 episodes in St Thomas's Hospital.

W R Gransden, S J Eykyn, I Phillips.   

Abstract

Four hundred episodes of Staphylococcus aureus bacteraemia occurred in St Thomas's Hospital from 1969 to 1983, accounting for 17.5% of all episodes of bacteraemia. The mortality was 24%, half attributable to underlying disease, and was highest in patients over 50. Almost 60% of the bacteraemias were acquired in hospital, and the source of the organism was generally obvious, with vascular access sites the most common (37%). Bone and joint infections accounted for 11.5% of episodes and endocarditis for 7%. Most staphylococci were resistant to penicillin only; three isolates were resistant to methicillin and five to fusidic acid. Microbiologists seldom influenced directly the choice of initial antibiotic treatment (though this usually conformed to the hospital's antibiotic prescribing policy) but had considerable influence over definitive treatment, usually cloxacillin or flucloxacillin alone or in combination with fusidic acid. S aureus bacteraemia is easy to identify and treat, though underlying disease may influence the outcome. Efforts should be made to prevent the largely iatrogenic disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6419907      PMCID: PMC1444067          DOI: 10.1136/bmj.288.6413.300

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  21 in total

1.  Natural history of 338 treated and untreated patients with staphylococcal septicaemia (1936-1955).

Authors:  I M SMITH; A B VICKERS
Journal:  Lancet       Date:  1960-06-18       Impact factor: 79.321

2.  Staphylococcal bacteraemia. Clinical and bacteriological observations in 201 cases.

Authors:  V FABER; O JESSEN; K ROSENDAL; K R ERIKSEN
Journal:  Br Med J       Date:  1960-12-24

3.  Changes in incidence and aetiology of bacteraemia arising in hospital practice.

Authors:  P J Watt; O A Okubadejo
Journal:  Br Med J       Date:  1967-01-28

4.  Combined treatment with antibacterial chemotherapeutical agents in staphylococcal infections.

Authors:  K Jensen; H C Lassen
Journal:  Q J Med       Date:  1969-01

5.  Changing staphylococci and staphylococcal infections. A ten-year study of bacteria and cases of bacteremia.

Authors:  O Jessen; K Rosendal; P Bülow; V Faber; K R Eriksen
Journal:  N Engl J Med       Date:  1969-09-18       Impact factor: 91.245

Review 6.  Antibiotic-resistant Staphylococcus aureus.

Authors:  D C Shanson
Journal:  J Hosp Infect       Date:  1981-03       Impact factor: 3.926

Review 7.  Increasing occurrence of methicillin-resistant Staphylococcus aureus in the United States.

Authors:  J M Boyce; W A Causey
Journal:  Infect Control       Date:  1982 Sep-Oct

8.  Prosthetic valve endocarditis.

Authors:  J Moore-Gillon; S J Eykyn; I Phillips
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-10

9.  Staphylococcus aureus bacteremia. Current clinical patterns.

Authors:  C M Nolan; H N Beaty
Journal:  Am J Med       Date:  1976-04       Impact factor: 4.965

10.  The association between Staphylococcus aureus bacteremia and bacteriuria.

Authors:  B K Lee; K Crossley; D N Gerding
Journal:  Am J Med       Date:  1978-08       Impact factor: 4.965

View more
  11 in total

Review 1.  Tropical pyomyositis (myositis tropicans): current perspective.

Authors:  S Chauhan; S Jain; S Varma; S S Chauhan
Journal:  Postgrad Med J       Date:  2004-05       Impact factor: 2.401

2.  Rationale for eliminating Staphylococcus breakpoints for β-lactam agents other than penicillin, oxacillin or cefoxitin, and ceftaroline.

Authors:  Jennifer Dien Bard; Janet A Hindler; Howard S Gold; Brandi Limbago
Journal:  Clin Infect Dis       Date:  2014-01-22       Impact factor: 9.079

3.  Pneumatoceles and pneumothoraces complicating staphylococcal pneumonia: treatment by synchronous independent lung ventilation.

Authors:  A W Lohse; O Klein; E Hermann; H Löhr; K F Kreitner; H Steppling; K H Meyer zum Büschenfelde; M Staritz
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

4.  Tropical Pyomyositis: Revisited.

Authors:  V Manikandan; Sandeep Mehrotra; Sunil Anand; Vinay Maurya
Journal:  Indian J Surg       Date:  2015-12-19       Impact factor: 0.656

5.  Tropical pyomyositis.

Authors:  L Ansaloni
Journal:  World J Surg       Date:  1996-06       Impact factor: 3.352

6.  Existing data sources for clinical epidemiology: The North Denmark Bacteremia Research Database.

Authors:  Henrik C Schønheyder; Mette Søgaard
Journal:  Clin Epidemiol       Date:  2010-08-09       Impact factor: 4.790

7.  Bacteraemia due to Staphylococcus aureus.

Authors:  S Ladhani; O S Konana; S Mwarumba; M C English
Journal:  Arch Dis Child       Date:  2004-06       Impact factor: 3.791

8.  Fusidic acid in infections of the external eye.

Authors:  O P van Bijsterveld; Y el Batawi; F S Sobhi; M W Nassar
Journal:  Infection       Date:  1987 Jan-Feb       Impact factor: 3.553

9.  Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital.

Authors:  W R Gransden; S J Eykyn; I Phillips
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-16

10.  Case of disseminated pyomyositis in poorly controlled type 2 diabetes mellitus with diabetic ketoacidosis.

Authors:  Akihito Tanabe; Hideaki Kaneto; Shinji Kamei; Yurie Hirata; Yuki Hisano; Junpei Sanada; Shintaro Irie; Tomoe Kinoshita; Fuminori Tatsumi; Masashi Shimoda; Kenji Kohara; Tomoatsu Mune; Kohei Kaku
Journal:  J Diabetes Investig       Date:  2015-08-19       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.